ImmunityBio, Inc. (IBRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.38 | +38.7% |
| 2024 | $-0.62 | +46.1% |
| 2023 | $-1.15 | -10.6% |
| 2022 | $-1.04 | -16.9% |
| 2021 | $-0.89 | -50.8% |
| 2020 | $-0.59 | -37.2% |
| 2019 | $-0.43 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.38 | +38.7% |
| 2024 | $-0.62 | +46.1% |
| 2023 | $-1.15 | -10.6% |
| 2022 | $-1.04 | -16.9% |
| 2021 | $-0.89 | -50.8% |
| 2020 | $-0.59 | -37.2% |
| 2019 | $-0.43 | — |